Redhill Biopharma (RDHL)
(Delayed Data from NSDQ)
$9.64 USD
-0.07 (-0.77%)
Updated Sep 25, 2024 03:47 PM ET
After-Market: $9.68 +0.04 (0.46%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Redhill Biopharma Ltd. [RDHL]
Reports for Purchase
Showing records 1 - 20 ( 229 total )
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Strategic Investment From South Korean Entity Announced; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Talicia Outlook Improving; Opaganib Subgroup Analyses; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Movantik Settlement Agreement Reached With Aurobindo; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Opaganib Misses Mark in COVID-19; Adjusting PT to $21
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
RHB-107 Phase 2/3 Trial Receives South African Authorization; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Opaganib Preclinical Data Reveals Impact on Kidney Fibrosis; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Opaganib Phase 2/3 Data Release Imminent; 2Q21 Financial Results; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Additional Settlement Reached on Movantik; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
RedHill Strengthens Coverage for Talicia; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Significant Movantik Market Access Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Opaganib Preclinical Activity Against SARS-CoV-2 Variants; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Opaganib Phase 2/3 COVID-19 Trial Enrollment Completion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R